Biorestorative Therapies (BRTX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BRTX Biorestorative Therapies

Watchlist

1.480
+0.035+2.42%

Close Nov 22 16:00 ET

1.461
-0.019-1.28%

Post 16:11 ET

10.24MMarket Cap-1034P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Maxim Group Maintains Biorestorative Therapies(BRTX.US) With Buy Rating, Maintains Target Price $6
Moomoo NewsNov 14 14:32 ET · Ratings
Positive Outlook for BioRestorative Therapies: Phase 2 Trial Results Drive Buy Rating
TipRanksNov 14 13:55 ET · Ratings
Roth MKM Remains a Buy on BioRestorative Therapies (BRTX)
TipRanksNov 14 08:11 ET · Ratings
BioRestorative Therapies, Inc. (BRTX) Q3 2024 Earnings Call Transcript Summary
moomoo AINov 13 20:14 ET · Conference Call
BioRestorative Therapies Showcases Promising Stem Cell Advances
TipRanksNov 13 16:44 ET
Biorestorative Therapies | 8-K: BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
SECNov 13 16:14 ET

Comments

Jaguar8

Nov 13 06:05

NEWS

$Biorestorative Therapies (BRTX.US)$
BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data
5 minutes ago, 4:00 AM PST
Via GlobeNewswire
– Blinded preliminary data demonstrate a positive trend and clear signal in Primary and Secondary endpoints –
– Patient reported efficacy outcomes show a material decrease in pain and increase in function –
– If positive trends continue, Company confident that the Phase 2 trial will meet its Primary and Secondary end points -
...

AdrianHHA

Nov 6 08:35

$Biorestorative Therapies (BRTX.US)$ https://newsfilter.io/a/a2906ce055b0b512cdbae48629f8595b

Teddy123

Nov 5 06:27

BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health

$Biorestorative Therapies (BRTX.US)$
MELVILLE, N.Y., Nov. 05, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced that it has received a provisional license from the New York State Department of Health (“NYSDOH”) for the pro...

Trytosaveabit

Nov 5 06:11

Update

$Biorestorative Therapies (BRTX.US)$ Reuters· just
BioRestorative Therapies Receives Expanded Tissue License From New York State Department of Health

Jaguar8

Oct 31 06:02

NEWS

$Biorestorative Therapies (BRTX.US)$
BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease Program
BioRestorative Therapies has received a Notice of Allowance from the Israel Patent Office for its ThermoStem® technology platform. This marks the 14th international patent outside the U.S. for this technology. The patent covers brown adipose derived stem cell (BADSC) aggregates, encapsulation systems, and treatment methods. The company believes ThermoStem®-based BA...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

BRTX Biorestorative Therapies

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target